ProCE Banner Events

Share

2025 Psychiatry Update for APPs

Register now for our Psychiatry Update 2025: NP/PA Series, which includes 5 dates in the spring and fall!

Join fellow healthcare professionals from around the nation for this popular series, now in its fifth year! This series covers similar topics to our long-standing Psychiatry Update series with a very practical curriculum to manage these illnesses, with a target audience specifically of NPs and PAs. Register now to secure your seat!

Nurse Practitioners/Nurses: 5.00 Nursing contact hours, including 5.00 hours of pharmacotherapy credit 

Physician Assistants/Physician Associates: 5.00 AAPA Category 1 CME credits

Who Should Attend

This activity is intended for physician associates and nurse practitioners engaged in the care of patients with psychiatric illness.

Time and location

Friday, October 24, 2025

9:00 AM - 3:35 PM Eastern Time (ET)

Virtual

Agenda

9:00 AM – 9:05 AM Opening Remarks

Moderated by Jeremy A. Schreiber, MSN, APRN, PMHNP-BC

 

9:05 – 10:05 AM Critical Screening and Timely Diagnosis of Tardive Dyskinesia in Older Adults: Evidence-Based Strategies for Clinical Practice

Presented by Jeremy A. Schreiber, MSN, APRN, PMHNP-BC

Master the critical importance of routine TD screening in older patients, who face elevated risks due to prolonged antipsychotic exposure and age-related physiological vulnerabilities. Explore validated assessment tools like the AIMS scale, learn to differentiate TD from other movement disorders, and integrate systematic screening protocols into clinical workflows to enable timely diagnosis and mitigate complications such as falls and dysphagia.

 

10:05 AM – 10:10 AM 5-minute Break

 

10:10 AM – 11:10 AM Advancing Clinical Decision-Making in MDD: Evidence-Based Strategies for Augmentation, Switching, and Personalized Treatment Plans

Presented by Tina Matthews-Hayes, DNP, CRNP, FNP-BC, PMHNP-BC

Develop collaborative MDD care plans by integrating practical augmentation/switching criteria, optimizing augmentation dosing and monitoring protocols, and addressing adherence barriers via case studies highlighting comorbidity management and patient-centered communication.

 

11:10 AM – 11:15 AM 5-minute Break

 

11:15 AM – 12:15 PM Transforming Patient-Centered Schizophrenia Care: Exploring Novel Therapeutic Strategies

Presented by Michael Asbach, DMSc, PA-C

Explore the role of novel molecules in reducing treatment burden and improving quality of life while emphasizing real-world challenges such as adverse events and psychosocial impacts. Learn about brand new mechanism and approaches and communicate evidence-based benefits to diverse populations.

 

12:15 PM – 12:20 PM 5-minute Break

 

12:20 PM – 1:20 PM Nonaccredited Educational Session, managed by Clinical Care Solutions, a CEA Company

 

1:20 PM – 1:25 PM 5-minute Break

 

1:25 PM – 2:25 PM Puberty to Menopause: The Impact of Hormone Fluctuations on Depression

Presented by Katrine Alcaide, MSN, ARNP, FNP-C, RN

Shifting levels of estrogen and progesterone correlate with changes in mood regulation throughout the lifespan. This session considers strategies to improve screening and intervention for mood disorders around times of hormonal shift (including peripartum and hormonal therapy) and suggests opportunities for patient education and discussion.

 

2:25 PM – 2:30 PM 5-minute Break

 

2:30 PM – 3:30 PM Steering Through Anxiety: Evidence-Based Navigation for Anxiety Disorders

Presented by Chelsie Monroe, MSN, APN, PMHNP-BC

Exploring evidence-based approaches to anxiety disorders, this session equips advanced practice providers with the skills to differentiate between anxiety subtypes and implement effective treatment strategies. Learn diagnostic markers to formulate first-line interventions, and design management plans that strategically sequence pharmacologic and non-pharmacologic approaches for optimal patient outcomes.

 

3:30 PM – 3:35 PM Closing Remarks

Moderated by Jeremy A. Schreiber, MSN, APRN, PMHNP-BC

CME/CE Info

Goal Statement
The goal of this activity is to improve the knowledge, competence, and performance of learners to assess diagnostic considerations and new and emerging therapies for the treatment of psychiatric illness. 

Target Audience
This activity is intended for physician associates and nurse practitioners engaged in the care of patients with psychiatric illness. 

Learning Objectives
Upon completion of this event, participants should be able to:

  • Assess latest clinical evidence on new and emerging treatment options for patients with psychiatric disorders
  • Develop individualized treatment strategies for optimal outcomes in patients with psychiatric disorders
  • Discuss best practices in psychiatry to optimize patient care

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 5.0 contact hours, including 5.0 hours of pharmacotherapy credit.

Physician Associate Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 5.0 AAPA Category 1 CME credits. PAs should only claim commensurate with the extent of their participation.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC, in partnership with Practicing Clinicians Exchange.

CCO 2022

Supporter

Supported by educational grants from Bristol-Myers Squibb, Intra-Cellular Therapies, Inc. and Neurocrine Biosciences. 

Bristol Myers Squibb

Intra-Cellular Therapies, Inc.

Neurocrine Biosciences

Partner

Practicing Clinicians Exchange

Practicing Clinicians Exchange

Contact Information

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Additional Information

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.